Badrivas Biotech Profile
Key Indicators
- Authorised Capital ₹ 6.00 M
- Paid Up Capital ₹ 5.40 M
- Company Age 20 Year, 26 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.36 Cr
- Revenue Growth -17.98%
- Profit Growth -2.53%
- Ebitda -372.42%
- Net Worth 4.40%
- Total Assets 31.75%
About Badrivas Biotech
Badrivas Biotech Private Limited (BBPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 14 January 2005 and has a history of 20 years. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 6.00 M and a paid-up capital of Rs 5.40 M.
The company currently has active open charges totaling ₹3.36 Cr.
Yoginder Singh, Shailendra Verma, and Praveen Kumar serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74920DL2005PTC132140
-
Company No.
132140
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
14 Jan 2005
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Badrivas Biotech?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shailendra Verma
|
Director | 31-Mar-2016 | Current |
|
Yoginder Singh
|
Additional Director | 20-Nov-2024 | Current |
|
Praveen Kumar
|
Director | 07-Feb-2024 | Current |
Financial Performance of Badrivas Biotech.
Badrivas Biotech Private Limited, for the financial year ended 2024, experienced significant reduction in revenue, with a 17.98% decrease. The company also saw a slight decrease in profitability, with a 2.53% decrease in profit. The company's net worth moved up by a moderate rise of 4.4%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Badrivas Biotech?
In 2024, Badrivas Biotech had a public holding of 99.91%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Badrivas Laboratory Private LimitedShailendra Verma is a mutual person
Charges (Loans)
₹33.60 M
₹0
Charges Breakdown by Lending Institutions
- Indian Overseas Bank : 2.08 Cr
- Sidbi : 1.29 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Nov 2023 | Indian Overseas Bank | ₹1.35 M | Open |
| 21 Sep 2021 | Sidbi | ₹1.00 Cr | Open |
| 13 Jul 2020 | Sidbi | ₹0.45 M | Open |
| 22 Sep 2018 | Sidbi | ₹2.40 M | Open |
| 15 Apr 2008 | Indian Overseas Bank | ₹1.94 Cr | Open |
How Many Employees Work at Badrivas Biotech?
Badrivas Biotech has a workforce of 6 employees as of Dec 18, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Badrivas Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Badrivas Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
